Pasithea Therapeutics Corp.

Ownership Transactions Reported by 17 Insiders

Symbol
KTTA, KTTAW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1111 Lincoln Road, Suite 500, Miami Beach, FL

Insiders trading volume in the past year

Pasithea Therapeutics Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PD Joint Holdings, LLC Series 2016-A 10%+ Owner $1.12M Oct 22, 2022
Eric Shahinian Member of 10% owner group $771K Sep 28, 2022
Israel Maxx Abramowitz Not a 10% owner $453K Sep 14, 2021
Eric Lazer Not a 10% owner $389K Sep 14, 2021
Dean Lazer Not a 10% owner $389K Sep 14, 2021
Lawrence Steinman Director $150K Nov 28, 2025
Yassine Bendiabdallah Chief Operating Officer, Director $129K Sep 14, 2021
David Delaney Member of 10% owner group $98.1K Oct 17, 2022
Tiago Marques Chief Executive Officer, Director $33K -$792 -2.34% Nov 28, 2025
Simon Dumesnil Director $26.9K Nov 28, 2025
Emer Leahy Director $25K Nov 28, 2025
Avi Geller Member of 10% owner group $23.6K Aug 19, 2022
Daniel Schneiderman Chief Financial Officer $20K Nov 28, 2025
Alfred J. Novak Director Oct 24, 2025
Graeme Currie Chief Development Officer Mar 1, 2024
Stanley Gloss Chief Financial Officer Sep 14, 2021
Leonite Fund I, LP Member of 10% owner group Aug 19, 2022

Recent Insider Transactions by Companies or Individuals for Pasithea Therapeutics Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.